In Vivo Role of NAD(P)H:Quinone Oxidoreductase 1 (NQO1) in the Regulation of Intracellular Redox State and Accumulation of Abdominal Adipose Tissue*
Abstract
NAD(P)H:quinone oxidoreductase 1 (NQO1) is a flavoprotein that utilizes NAD(P)H as an electron donor, catalyzing the two-electron reduction and detoxification of quinones and their derivatives. NQO1−/− mice deficient in NQO1 activity and protein were generated in our laboratory (Rajendirane, V., Joseph, P., Lee, Y. H., Kimura, S., Klein-Szanto, A. J. P., Gonzalez, F. J., and Jaiswal, A. K. (1998) J. Biol. Chem. 273, 7382–7389). Mice lacking a functional NQO1 gene (NQO1−/−) were born normal and reproduced adeptly as the wild-type NQO1+/+ mice. In the present report, we show that NQO1−/− mice exhibit significantly lower levels of abdominal adipose tissue as compared with the wild-type mice. The NQO1−/− mice showed lower blood levels of glucose, no change in insulin, and higher levels of triglycerides, β-hydroxy butyrate, pyruvate, lactate, and glucagon as compared with wild-type mice. Insulin tolerance test demonstrated that the NQO1−/− mice are insulin resistant. The NQO1−/− mice livers also showed significantly higher levels of triglycerides, lactate, pyruvate, and glucose. The liver glycogen reserve was found decreased in NQO1−/− mice as compared with wild-type mice. The livers and kidneys from NQO1−/− mice also showed significantly lower levels of pyridine nucleotides but an increase in the reduced/oxidized NAD(P)H:NAD(P) ratio. These results suggested that loss of NQO1 activity alters the intracellular redox status by increasing the concentration of NAD(P)H. This leads to a reduction in pyridine nucleotide synthesis and reduced glucose and fatty acid metabolism. The alterations in metabolism due to redox changes result in a significant reduction in the amount of abdominal adipose tissue.
- NQO1
- first cytosolic form of NAD(P)H:quinone oxidoreductase also known as DT diaphorase
- NAD(P)H:quinone acceptor oxidoreductase
- quinone reductase
- NQO2
- a second cytosolic form of NAD(P)H:quinone oxidoreductases
- NAD(P)
- NAD and NADP combined
- NAD(P)H
- NADH and NAD(P)H combined
- HPLC
- high performance liquid chromatography
- Received February 4, 2001.
- Revision received March 28, 2001.
- The American Society for Biochemistry and Molecular Biology, Inc.











